Indications and Outcomes of Allogeneic Stem Cell Transplant for Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors

The need for an allogeneic stem cell transplant (HCT) for management of CML has decreased in the TKI era, yet in the setting of resistance or intolerance to TKIS, HCT may be the only remaining treatment option.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Kendra Sweet, Josephine Emole, Asmita Mishra, Javier Pinilla-Ibarz Source Type: research